Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Kidney Neoplasms × aldesleukin × Clear all

Phase

Phase 2 19 Phase 3 6 Phase 1/2 6 Phase 1 5 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Brain Neoplasms 1

Interventions

perflutren 1 denileukin diftitox 1 aldesleukin 1 Sorafenib 1 Microscopy, Electron 1 Interleukin-2 1 CYT-6091 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00278369 2013-05-22

Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

Northwestern University

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡